The short-chain fatty acid acetate for improving age-associated arterial dysfunction
Primary Objective
This study plans to learn more about whether acetate supplementation is an effective means of improving blood vessel function in healthy adults over 50 years of age. Acetate is a substance that is naturally produced by bacteria that live in your gut when you eat fiber. Acetate is considered an investigational drug in this study because it is not currently approved by the FDA for treatment of cardiovascular disease.
Description
If you join this study, you will participate in Screening, Baseline, Study Period, and End of Study visits over a ~4-month period. These visits will take about 14 hours of your time total. The study visits will take place at the Division of Renal Diseases and Hypertension Clinical Research Unit located in the CU Medicine building on the CU Anschutz Medical Campus.
Details
Locations
Anschutz Health and Wellness
Department Specific Free Standing Clinic
Principal Investigator
Vienna Brunt
Study ID
Protocol Number: 22-0473
More information available at ClinicalTrials.gov: NCT05424263
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers